Highlights of June 2023 1. Lupin receives $25 Million from AbbVie as a part of a strategic partnership to initiat...
Read MoreHighlights of May 2023 1. Sun Pharma to acquire Taro Pharma's 100% stake in all-cash for around US$300 million th...
Read MoreHighlights of April 2023 1. Cash rich Serum Institute of India to double investment in Biocon's unit to INR 2,455...
Read MoreHighlights of March 2023:Aurobindo, Cipla, Viatris in licensing pact with MPP(Medicine Patent Pool) to make ViiV's HIV preventive therapy.Lotus Surgic...
Read MoreHighlights of February 2023:India's Biocon raises US$129 Million from Kotak to fund biosimilars deal.Marengo Asia Healthcare acquires 1...
Read MoreHighlights of January 2023Sun Pharma acquires U.S.-based Concert Pharma for $576 million, to gain access to its experimental drug for treating patchy ...
Read MoreHighlights of December 2022Private equity giant Advent International will acquire a 50.1% stake in Suven Pharmaceuticals from Jasti family for nearly ...
Read MoreHighlights of November 2022Gland Pharma buys Cenexi Group for €120 Million.Mankind Pharma acquires majority stake in Upakarma Ayurveda.Lupin's Brazi...
Read MoreHighlights of October 2022Lupin Signs Agreement to Acquire Two Inhalation Brands from Sunovion.Hetero acquires Johnson & Johnson's manufacturing p...
Read MoreHighlights of September 2022Lupin, DKSH sign agreement to commercialize five biosimilar candidates in Philippines.Dr. Reddy’s Labs partners with IQV...
Read More